Specialty Enzymes

Published by: Global Industry Analysts

Published: Feb. 1, 2007 - 242 Pages

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions And Scope Of Study

Specialty Medical Enzymes

Polymerases

Nucleases

Other Specialty Enzymes

Pharmaceuticals/Diagnostic

Research/Biotechnology

II. EXECUTIVE SUMMARY

1. Introduction

Introduction

2. Global Market Overview

Global Market Overview

3. Enzymes- A Review

Definition

Introduction

Advantages of Enzymes Compared to Chemical Catalysts

Table 1: Enzymes Market Worldwide (2005 & 2006E): Market Share of Leading Players- Novozymes, Genencol, DSM, BASF and Others (includes corresponding Graph/Chart)

A Brief History

4. Specialty Enzymes: An Overview

Analysis of Product Segments

Specialty Medical Enzymes

Market Analytics

Polymerases

Market Analytics

Nucleases

Market Analytics

Other Specialty Enzymes

5. Analysis of the End-Use Markets

Pharmaceuticals & Diagnostics

Research/Biotechnology

Other End Use Markets

6. Technology Trends

Protein Engineering Technology

Specialty Enzymes in Industrial Uses

7. Product Innovations/Introductions

MARDI Develops Taq DNA Polymerase

Stratagene Corporation Commercializes DNA Polymerases

Takara Bio Launches PrimeSTAR HS DNA Polymerase

Verdia and Pioneer Hi-Bred International Develops Glyphosate-Resistant Crop Trait

8. Recent Industry Activity

Solexa Signs Agreement with New England Biolabs

Danisco Takes Over Genencor

IBEX Technologies Inks Agreement with Cape Cod and Prozyme

Industry Activity in the Recent Past

Genencor Buys Brewing and Enzyme Businesses of Rhodia

Genencor Acquires Enzyme Bio-Systems

Novozymes A/S Acquires BioGaia

Diversa Develops New Enzymes with DuPont Bio-Based Materials

Diversa Signs Agreement with Degussa

Hyalose and Novozymes Enter into a Contract for the Production of Enzymes

Genencor Increases Production Capacity

SPIC Divests Biotech Unit

Proteus and Bern Varsity Sign Agreement

Novartis Signs Research Agreement with Vertex Pharmaceuticals

9. Technological Developments in Recent Past

Novozymes Creates Lipase Enzyme

PNNL Develops New Method to Immobilize Enzymes

Hayashibara Develops New Method to Produce Cyclic Tetrasaccharide

Shionogi and Fujitsu Kyushu Create P450 Enzyme- Databases

Triarco Industries Launches Patented Enzyme Systems

10. Product Developments- Mid 90s

Product Developments- Mid 90s

11. Focus on Select Players Worldwide

Advanced Enzymes Technologies Limited (India)

Amano Enzyme Inc. (Japan)

Aureozyme Inc. (USA)

Biocon Ltd. (India)

Biozyme Laboratories (UK)

Danisco (Denmark)

Genencor International, Inc. (USA)

Diversa Corporation (USA)

Kinetic Biosystems, Inc. (USA)

Maxygen Inc (USA)

Novozymes (Denmark)

Seravac Biotech (Pty) Ltd (South Africa)

Specialty Enzymes and Biochemicals Co. (USA)

12. Global Market Perspective

Table 2: World Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 3: World 11-Year Perspective for Specialty Enzymes by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 4: World Recent Past, Current & Future Analysis for Specialty Medical Enzymes by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 5: World 10-Year Perspective for Specialty Medical Enzymes by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 6: World Recent Past, Current & Future Analysis for Polymerases by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 7: World 10-Year Perspective for Polymerases by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 8: World Recent Past, Current & Future Analysis for Nucleases by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 9: World 10-Year Perspective for Nucleases by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 10: World Recent Past, Current & Future Analysis for Other Specialty Enzymes by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 11: World 10-Year Perspective for Other Specialty Enzymes by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 12: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region/Country- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 13: World 10-Year Perspective for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 14: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region/Country- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 15: World 10-Year Perspective for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 16: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Other End-Use Markets by Geographic Region/Country- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 17: World 10-Year Perspective for Specialty Enzymes Consumption in Other End-Use Markets by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

A. Market Analysis

Market Dynamics

Specialty Enzymes Market is Projected to Rise 7% Annually

Specialty Enzymes Form the Leading Enzymes Segment

Pharmaceuticals and Diagnostics Continue to be the Largest Market

Specialty Medical Enzymes in a Myriad of Novel Applications

Market for Enzymes in Biotechnology

Product Launch

Strategic Corporate Developments

Key Players

Aureozyme Inc

Diversa Corporation

Genencor International, Inc

Kinetic Biosystems, Inc

Maxygen Inc

Specialty Enzymes and Biochemicals Co

B. Market Analytics

Table 18: US Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 19: US Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 20: US 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 21: US 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

2. Canada

Market Analysis

Table 22: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)

Table 23: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 24: Canadian 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 25: Canadian 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

3. Japan

A. Market Analysis

Technological Developments in Recent Past

Product Launch

Amano Enzyme Inc. - A Key Japanese Player

B. Market Analytics

Table 26: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 27: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 28: Japanese 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 29: Japanese 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4. Europe

A. Market Analysis

Strategic Corporate Developments in Recent Past

B. Market Analytics

Table 30: European Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region/ Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 31: European Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 32: European Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 33: European 11-Year Perspective for Specialty Enzymes by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 34: European 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 35: European 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4a. France

Market Analysis

Table 36: French Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 37: French Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 38: French 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 39: French 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4b. Germany

Market Analysis

Table 40: German Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 41: German Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 42: German 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 43: German 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4c. Italy

Market Analysis

Table 44: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 45: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 46: Italian 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 47: Italian 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4d. The United Kingdom

A. Market Analysis

Biozyme Laboratories Limited - A Major UK Player

B. Market Analytics

Table 48: UK Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 49: UK Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes correspondingGraph/Chart)

Table 50: UK 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 51: UK 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4e. Spain

Market Analysis

Table 52: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 53: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)

Table 54: Spanish 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010(includes corresponding Graph/Chart)

Table 55: Spanish 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010(includes corresponding Graph/Chart)

4f. Russia

Market Analysis

Table 56: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 57: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 58: Russian 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 59: Russian 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

4g. Rest of Europe

A. Market Analysis

Strategic Corporate Development

Key Players

Danisco (Denmark)

Novozymes (Denmark)

B. Market Analytics

Table 60: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 61: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 62: Rest of Europe 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 63: Rest of Europe 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

5. Asia-Pacific

A. Market Analysis

Product Launch

Strategic Corporate Developments in Recent Past

Key Players

Advanced Enzymes Technologies Limited (India)

Biocon Ltd. (India)

B. Market Analytics

Table 64: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 65: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 66: Asia-Pacific 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 67: Asia-Pacific 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

6. The Middle East

A. Market Analysis

Key Player

Seravac Biotech (Pty) Ltd (South Africa)

B. Market Analytics

Table 68: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 69: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)

Table 70: Middle East 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 71: Middle East 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

7. Latin America

Market Analysis

Table 72: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 73: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segments- Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)

Table 74: Latin American 11-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 75: Latin American 11-Year Perspective for Specialty Enzymes by End-Use Segments - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart)

IV. COMPETITION

1. AB Enzymes GmbH (Germany)

2. Abazyme (USA)

3. Advanced Enzyme Technologies Ltd. (India)

4. Alator Biosciences (USA)

5. Amano Enzyme, Inc. (Japan)

Amano Enzyme USA Co., Ltd. (USA)

6. Ambion, Inc. (USA)

7. Athenaes (USA)

8. Aureozyme, Inc. (USA)

9. Biocatalysts Ltd. (UK)

10. Biocon India Ltd. (India)

Table 76: First Quarter Sales Analysis: 2006-2007 (In INR million)

Table 77:Annual Sales Analysis: 2004-2006 (In INR million)

Table 78 : Annual Sales Analysis by Segment: 2005-2006 (In INR million)

Table 79: Annual Sales Analysis by Segment: 2004-2005 (In INR million)

11. Biozyme Laboratories Ltd. (UK)

12. Codexis, Inc. (USA)

13. Danisco A/S (Denmark)

Table 80: Annual Sales Analysis: 2004-2006 (In DKK million)

Table 81: Annual Sales Analysis by Segment: 2005-2006 (In DKK million)

Table 82: Annual Sales Analysis by Geographic Region: 2005-2006 (In DKK million)

Table 83: Annual Sales Analysis by Segment: 2004-2005 (In DKK million)

Table 84: Annual Sales Analysis by Geographic Region: 2004-2005 (In DKK million)

Genencor International, Inc. (USA)

14. Deerland Enzymes, Inc. (USA)

15. Diagnostic Chemicals Limited (Canada)

16. Diversa Corporation (USA)

Table 85: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 86: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 87: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 88: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 89: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 90: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

17. DSM NV (The Netherlands)

Table 91: Annual Sales Analysis: 2004-2005 (In € million)

Table 92: Annual Sales Analysis by Business Segment: 2004-2005 (In € million)

18. Dyadic International, Inc. (USA)

Table 93: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 94: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 95: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 96: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

19. Epicentre Biotechnologies (USA)

20. Fermentas AB (Lithuania)

21. Finnzymes Oy (Finland)

22. Genzyme Corporation (USA)

Table 97: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 98: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 99: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 100: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 101: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 102: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 103: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

23. Hyalose LLC (USA)

24. IBEX Technologies, Inc. (IBT) (Canada)

Table 104: Annual Sales Analysis: 2004-2006 (In Can$ thousands)

Table 105: Quarterly Sales Analysis: 2004-2005 (In Can$ thousands)

25. Iogen Corporation (Canada)

26. KBI Biopharma, Inc. (USA)

27. MARDI (Malaysia)

28. Maxygen, Inc. (USA)

Table 106: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 107: Nine Months Sales Analysis by Business Segment: 2005-2006 (Nine Months Ended September) (In US$ million)

Table 108: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 109: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million)

Table 110: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

29. Minotech Biotechnology (Greece)

30. New England Biolabs, Inc. (USA)

31. Novozymes A S (Denmark)

32. Promega Corporation (USA)

33. Proteus Biosciences, Inc. (USA)

34. ProZyme, Inc. (USA)

35. Qiagen NV (The Netherlands)

Table 111: Nine Months Sales Analysis: 2005-2006 (Nine months Ended, September) (In US$ million)

Table 112: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine months Ended, September) (In US$ million)

Table 113: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 114: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

36. Reliable Biopharmaceutical Corporation (USA)

37. Roche Applied Science (USA)

38. Sanosil Ltd. (Switzerland)

39. Seravac Biotech (Pty.,) Ltd. (South Africa)

40. Solexa, Inc. (USA)

Table 115: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ thousands)

Table 116: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ thousands)

Table 117: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ thousands)

Table 118: Annual Sales Analysis: 2004-2005 (In US$ thousands)

Table 119: Annual Sales Analysis by Quarter: 2004-2005 (In US$ thousands)

Table 120: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ thousands)

41. Specialty Enzymes And Biochemicals Co. (USA)

42. Southern Petrochemicals Industries Corporation Ltd. (India)

Table 121: Annual Sales Analysis: 2004-2005 (In INR million)

43. Stratagene, Inc. (USA)

Table 122: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 123: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 124: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 125: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 126: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 127: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

44. Takara Bio, Inc. (Japan)

Table 128: Annual Sales Analysis: 2004-2006 (In ¥ billion)

Table 129: Annual Sales Analysis by Segment: 2005-2006 (In ¥ billion)

Table 130: Annual Sales Analysis by Geographic Region: 2005-2006 (In ¥ billion)

Table 131: Annual Sales Analysis by Segment: 2004-2005 (In ¥ billion)

Table 132: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ billion)

Abstract

This report analyzes the worldwide markets for Specialty Enzymes in Millions of US$. The specific product segments analyzed are Specialty Medical Enzymes, Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use segments discussed are Pharmaceuticals & Diagnostics, and Research/Biotechnology. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 44 companies including many key and niche players worldwide such as Advanced Enzymes Technologies Limited, Amano Enzyme Inc., Aureozyme Inc., Biocon Ltd., Biozyme Laboratories, Danisco, Genencor International, Inc., Diversa Corporation, Kinetic Biosystems, Inc., Maxygen Inc, Novozymes, Seravac Biotech (Pty) Ltd, and Specialty Enzymes and Biochemicals Co. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies (when hard copy is available)is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your personal library immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.